Differential Recruitment of Dendritic Cells Subsets to Lymph Nodes Correlates with a Protective or Permissive T-Cell Response during Leishmania (Viannia) Braziliensis or Leishmania (Leishmania) Amazonensis Infection

Carregando...
Imagem de Miniatura
Citações na Scopus
13
Tipo de produção
article
Data de publicação
2016
Título da Revista
ISSN da Revista
Título do Volume
Editora
HINDAWI PUBLISHING CORP
Citação
MEDIATORS OF INFLAMMATION, article ID 7068287, 12p, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Leishmania (L.) amazonensis (La) and L. (V.) braziliensis (Lb) are responsible for a large clinical and immunopathological spectrum in human disease; while La may be responsible for anergic disease, Lb infection leads to cellular hypersensitivity. To better understand the dichotomy in the immune response caused by these Leishmania species, we evaluated subsets of dendritic cells (DCs) and T lymphocyte in draining lymph nodes during the course of La and Lb infection in BALB/c mice. Our results demonstrated a high involvement of DCs in La infection, which was characterized by the greater accumulation of Langerhans cells (LCs); conversely, Lb infection led to an increase in dermal DCs (dDCs) throughout the infection. Considering the T lymphocyte response, an increase of effector, activated, and memory CD4(+) T-cells was observed in Lb infection. Interleukin- (IL-) 4- and IL-10- producing CD4(+) and CD8(+) T-cells were present in both La and Lb infection; however, interferon-(IFN-) gamma-producing CD4(+) and CD8(+) T-cells were detected only in Lb infection. The results suggest that during Lb infection, the dDCs were the predominant subset of DCs that in turn was associated with the development of Th1 immune response; in contrast La infection was associated with a preferential accumulation of LCs and total blockage of the development of Th1 immune response.
Palavras-chave
Referências
  1. Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152
  2. Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490
  3. Silveira FT, 2009, PARASITE IMMUNOL, V31, P423, DOI 10.1111/j.1365-3024.2009.01116.x
  4. Carvalho AK, 2012, PARASITE IMMUNOL, V34, P395, DOI 10.1111/j.1365-3024.2012.01370.x
  5. Castellucci L, 2006, J INFECT DIS, V194, P519, DOI 10.1086/505504
  6. Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964
  7. Soong L, 2012, SEMIN IMMUNOPATHOL, V34, P735, DOI 10.1007/s00281-012-0350-8
  8. Okwor IB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003300
  9. Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455
  10. Novais FO, 2015, SEMIN IMMUNOPATHOL, V37, P251, DOI 10.1007/s00281-015-0475-7
  11. Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904
  12. Melief CJM, 2003, EUR J IMMUNOL, V33, P2645, DOI 10.1002/eji.200324341
  13. Favali C, 2007, J LEUKOCYTE BIOL, V82, P1401, DOI 10.1189/jlb.0307187
  14. Valladeau J, 2005, SEMIN IMMUNOL, V17, P273, DOI 10.1016/j.smim.2005.05.009
  15. Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623
  16. Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909
  17. Herath S, 2003, PARASITE IMMUNOL, V25, P559, DOI 10.1111/j.0141-9838.2004.00668.x
  18. MULLER I, 1991, INT IMMUNOL, V3, P587, DOI 10.1093/intimm/3.6.587
  19. Ruiz JH, 2007, PARASITE IMMUNOL, V29, P671, DOI 10.1111/j.1365-3024.2007.00991.x
  20. Passero LFD, 2010, PARASITOL INT, V59, P159, DOI 10.1016/j.parint.2009.12.010
  21. Campanelli AP, 2006, J INFECT DIS, V193, P1313, DOI 10.1086/502980
  22. Kautz-Neu K, 2011, J EXP MED, V208, P885, DOI 10.1084/jem.20102318
  23. Ritter U, 2004, EUR J IMMUNOL, V34, P1542, DOI 10.1002/eji.200324586
  24. Ji JX, 2005, J IMMUNOL, V174, P7147
  25. Falcao SC, 2012, INT J PARASITOL, V42, P771, DOI 10.1016/j.ijpara.2012.05.006
  26. Blackwell JM, 1999, PARASITOL TODAY, V15, P73, DOI 10.1016/S0169-4758(98)01355-6
  27. Qi H, 2001, J IMMUNOL, V167, P4534
  28. Brewig N, 2009, J IMMUNOL, V182, P774
  29. Brown JA, 1996, J INFECT DIS, V174, P1303
  30. Silveira FT, 2004, MEM I OSWALDO CRUZ, V99, P239, DOI 10.1590/S0074-02762004000300001
  31. BLANK C, 1993, J INFECT DIS, V167, P418
  32. Xavier MB, 2005, ACTA TROP, V95, P67, DOI 10.1016/j.actatropica.2005.04.016
  33. Clausen BE, 2010, IMMUNOL CELL BIOL, V88, P351, DOI 10.1038/icb.2010.40
  34. Lakhal-Naouar I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004178
  35. MOLL H, 1993, ADV EXP MED BIOL, V329, P587
  36. Ng LG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000222
  37. SCHULER G, 1985, J EXP MED, V161, P526, DOI 10.1084/jem.161.3.526